Jefferies initiates buy on Krystal Biotech with a $245 price target, citing Vyjuvek's strong growth potential and proprietary ...

Fintel reports that on March 5, 2025, Jefferies initiated coverage of Krystal Biotech (NasdaqGS:KRYS) with a Buy ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...

Would you like to be notified of the latest news and updates on the stock market?